State Ledger
Company profile

IMPACT BIOMEDICAL INC. CIK 1834105

Ticker
IBO (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Houston, TX 77084
Fiscal year end
2025 (FY)
Market Data
Close
$4.23
Change
-$0.32
Change %
-7.03%
Volume
369

IBO · trading date Oct 8, 2026 · previous close $4.55 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$32.0K
Net income
-$11.84M
Total assets
$17.41M
Total liabilities
$1.85M
Stockholders' equity
$12.61M
Cash & equivalents
$3.0K
Operating income
-$4.28M
Operating cash flow
-$1.89M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-11. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-13,381.3%
Net margin
-36,993.8%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
10.6%
Equity / assets
72.4%
CapEx / revenue
—
Operating cash flow / net income
0.16×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $32.0K -$11.84M $17.41M $1.85M $12.61M
2024 — -$24.71M $20.29M $13.05M $4.26M
2023 — -$4.34M $44.63M $16.37M $25.22M
2022 $50.0K -$7.26M $46.50M $13.83M $29.56M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 425
2026-09-17
Financials filed via
Form 10-K
filed 2026-03-11

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Houston, TX 77084
1400 BROADFIELD BLVD.
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:58 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies